Crinetics Pharmaceuticals, Inc. (CRNX) Cash flow
Market cap
$7.9B
P/E ratio
| 2018/12 | 2019/12 | 2020/12 | 2021/12 | 2022/12 | 2023/12 | 2024/12 | |
| Stock-based compensation | 2 | 6 | 10 | 17 | 28 | 41 | 69 |
| Cash from operations | -19 | -46 | -62 | -89 | -115 | -166 | -226 |
| Capital expenditures | -1 | -0 | -0 | -0 | -2 | -5 | -4 |
| Cash from investing | -119 | 42 | 0 | -56 | -174 | -200 | -575 |
| Cash from financing | 170 | 0 | 115 | 253 | 122 | 389 | 1,010 |
| Free cash flow | |||||||
| FCF margin (%) | - | - |